Review: taking Coumadin and Glucosamine sulphate together


Summary

Drug interactions are reported among people who take Coumadin and Glucosamine sulphate together. This review analyzes the effectiveness and drug interactions between Coumadin and Glucosamine sulphate. It is created by eHealthMe based on reports of 66 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Glucosamine sulphate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 80,735 users)

Glucosamine Sulphate

Glucosamine sulphate has active ingredients of glucosamine sulfate. It is often used in arthritis. (latest outcomes from Glucosamine sulphate 52 users)

On Aug, 22, 2016

66 people who take Coumadin, Glucosamine Sulphate are studied.


Number of reports submitted per year:

Coumadin and Glucosamine sulphate drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Glucosamine Sulphate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Glucosamine Sulphate:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Glucosamine Sulphate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

1 - 6 months:
  • gastric ulcer haemorrhage
  • urinary tract infection
not specified:
  • dyspnoea
  • pain
  • atrial fibrillation
  • back pain
  • haematuria
  • nausea
  • fatigue
  • pneumonia
  • arthralgia
  • oedema peripheral

Most common drug interactions by gender *:

female:
  • fatigue
  • fall
  • aortic stenosis
  • aortic valve calcification
  • asthenia
  • muscle spasms
  • pain in extremity
  • drug ineffective
  • blood calcium decreased
  • contusion
male:
  • atrial fibrillation
  • back pain
  • pneumonia
  • arthralgia
  • oedema peripheral
  • arrhythmia
  • cholelithiasis
  • dyspnoea
  • haematuria
  • osteoporosis

Most common drug interactions by age *:

20-29:
  • gait disturbance
  • balance disorder
  • blood cholesterol increased
  • blood pressure systolic increased
  • bradycardia
  • cerebellar infarction
  • coordination abnormal
  • drug ineffective
  • hemiparesis
  • mobility decreased
30-39:
  • prothrombin level decreased
  • prothrombin level increased
  • thrombophlebitis deep
40-49:
  • fatigue
  • blood bilirubin increased
  • contusion
  • disturbance in attention
  • feeling hot
  • flushing
  • haemolysis
  • melaena
  • nausea
  • platelet count decreased
50-59:
  • fall
  • cough
  • drug ineffective
  • dyspepsia
  • ear discomfort
  • excoriation
  • gastric disorder
  • gastrooesophageal reflux disease
  • joint injury
  • sinus congestion
60+:
  • atrial fibrillation
  • fatigue
  • aortic stenosis
  • aortic valve calcification
  • haematuria
  • muscle spasms
  • pain in extremity
  • fall
  • blood calcium decreased
  • exercise tolerance decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Glucosamine sulphate?

Can you answer these questions?

More questions for: Coumadin, Glucosamine sulphate

You may be interested in these reviews

More reviews for: Coumadin, Glucosamine sulphate

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Glucosamine sulphate (glucosamine sulfate) is often used to treat arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.